Well Pharma Medical Research
Generated 5/3/2026
Executive Summary
Well Pharma Medical Research (WPMR) is a private, multi-specialty clinical research site organization headquartered in Miami, Florida. Founded in 2006 and led by Dr. Eddie Armas, WPMR conducts Phase I through IV clinical trials across various therapeutic areas for pharmaceutical sponsors and CROs. Leveraging its long-standing presence in the South Florida research ecosystem, the company has built a reputation for patient recruitment and trial execution. While facing competition from larger SROs, WPMR's flexibility and seasoned investigator network position it to capitalize on growing demand for decentralized and site-centric trials. The company's outlook is tied to its ability to secure new contracts and expand into high-growth indications.
Upcoming Catalysts (preview)
- Q3 2026Award of New Phase II/III Clinical Trial Contracts70% success
- Q4 2026Expansion into Neurology or Rare Disease Trials50% success
- H2 2026Strategic Partnership with a Top CRO or Sponsor60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)